Submitted by Anonymous (not verified) on 8 May 2026 - 13:40
Human medicines European public assessment report (EPAR): Bimzelx, bimekizumab, Date of authorisation: 20/08/2021, Revision: 14, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Bimzelx, bimekizumab, Date of authorisation: 20/08/2021, Revision: 14, Status: Authorised